Baxter International Inc. has agreed to sell its kidney care business unit to global investment firm Carlyle for $3.8b, the companies announced on 13 August.
The business will be known
Baxter Ready To Offload Kidney Care Unit
Global investment firm Carlyle has agreed to pay $3.8b for Baxter International’s Kidney Care unit. The newly spun-off business will be known as Vantive.
